Envista Holdings Corporation $NVST Shares Sold by Pzena Investment Management LLC

Pzena Investment Management LLC reduced its position in shares of Envista Holdings Corporation (NYSE:NVST) by 3.7% during the fourth quarter, HoldingsChannel reports. The firm owned 2,325,859 shares of the company’s stock after selling 89,007 shares during the quarter. Pzena Investment Management LLC’s holdings in Envista were worth $50,494,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in NVST. Tudor Investment Corp ET AL bought a new stake in shares of Envista in the third quarter worth $1,664,000. ARGA Investment Management LP bought a new stake in shares of Envista in the third quarter worth $950,000. First Eagle Investment Management LLC bought a new stake in shares of Envista in the third quarter worth $4,329,000. Massachusetts Financial Services Co. MA increased its stake in shares of Envista by 22.0% in the third quarter. Massachusetts Financial Services Co. MA now owns 2,905,149 shares of the company’s stock worth $59,178,000 after buying an additional 523,949 shares during the last quarter. Finally, Jupiter Asset Management Ltd. increased its stake in shares of Envista by 24.6% in the third quarter. Jupiter Asset Management Ltd. now owns 1,349,042 shares of the company’s stock worth $27,480,000 after buying an additional 266,671 shares during the last quarter.

Analyst Ratings Changes

A number of brokerages recently issued reports on NVST. JPMorgan Chase & Co. lifted their price target on shares of Envista from $26.00 to $29.00 and gave the stock a “neutral” rating in a research note on Thursday, May 7th. Evercore restated an “outperform” rating and issued a $33.00 price target on shares of Envista in a research note on Thursday, May 7th. Wells Fargo & Company lifted their price target on shares of Envista from $21.00 to $26.00 and gave the stock an “equal weight” rating in a research note on Friday, February 6th. Wall Street Zen lowered shares of Envista from a “strong-buy” rating to a “buy” rating in a research note on Saturday, May 9th. Finally, Morgan Stanley boosted their target price on shares of Envista from $19.00 to $21.00 and gave the company an “equal weight” rating in a research note on Friday, April 24th. Six equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $28.83.

Envista Stock Performance

Shares of NVST opened at $23.63 on Friday. Envista Holdings Corporation has a 1 year low of $16.41 and a 1 year high of $30.42. The company has a market cap of $3.85 billion, a price-to-earnings ratio of 57.65, a price-to-earnings-growth ratio of 1.49 and a beta of 0.92. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.06 and a current ratio of 2.44. The firm has a fifty day moving average of $25.64 and a 200-day moving average of $24.31.

Envista (NYSE:NVST) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.05. Envista had a net margin of 2.41% and a return on equity of 7.11%. During the same quarter in the prior year, the business earned $0.24 earnings per share. The company’s quarterly revenue was up 14.4% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. As a group, equities analysts anticipate that Envista Holdings Corporation will post 1.43 earnings per share for the current year.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.